Elicera Therapeutics AB (publ) (FRA:8E8)
Germany · Delayed Price · Currency is EUR 0.4820
0.00 (0.00%)
Last updated: Dec 1, 2025, 8:05 AM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of €28.92 million as of December 1, 2025. Its market cap has increased by 384.62% in one year.
Market Cap
28.92M
Enterprise Value
25.74M
Revenue
1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.48
Market Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 12.18M to 28.92M, an increase of 137.39%. That is a compound annual growth rate of 21.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 24.19M | 372.96% |
| Dec 30, 2024 | 5.11M | -36.80% |
| Dec 29, 2023 | 8.09M | 29.64% |
| Dec 30, 2022 | 6.24M | -35.63% |
| Dec 30, 2021 | 9.70M | -20.40% |
| Jun 11, 2021 | 12.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |